Over the past several years a major shift has been taking place in the global manufacturing landscape. Increasing numbers of multinational corporations are moving part of their production to India.
Shares of major European pharmaceutical firms declined on Friday after U.S. President Donald Trump sent letters to 17 global drugmakers demanding they align U.S. prices with those offered in other countries. The move follows a sweeping executive order signed earlier this year aimed at curbing high drug costs in the United States.
11 Mar 2026-23:15
